Pfizer unveils new Phase 2 data on 20-valent pneumococcal conjugate vaccine
April 15, 2019Research and Development, Sales and Marketing Pfizer, Streptococcus pneumoniae, Vaccine, pharma
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC), detailing the …
Bowel cancers adjust themselves to hide from immunotherapies
April 15, 2019Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour
Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …
Doctors treat porphyria using innovative gene silencing drug
April 15, 2019Sales and Marketing RNA, gene silencing, genetics, givosiran, health, porphyria
Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug. Speaking to the BBC, Professor David Rees, from King’s College …
Janssen’s Balversa becomes first FDA-approved FGFR kinase inhibitor for advanced bladder cancer
April 15, 2019Sales and Marketing Balversa, Cancer, FDA, Janssen, bladder cancer, pharma
Janssen’s Balversa (erdafitinib) has become the first FDA-approved fibroblast growth factor receptor (FGFR) kinase inhibitor after the US agency authorised …
Medical cannabis: A green light for patients in need?
April 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Clovis Oncology discontinue phase 2 bladder cancer trial
April 15, 2019Sales and Marketing Cancer, Clovis Oncology, US, bladder cancer, metastatic bladder cancer
Colorado-based pharma firm Clovis Oncology has said in a filing to the US Securities and Exchange Commission that it is …
Bayer VP elected to two of the firm’s executive committees
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment
Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
GW Pharma announce Darren Cline as company’s new Chief Commercial Officer
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
FDA expands Keytruda label to include stage 3 and 4 non-small cell lung cancer
April 12, 2019Medical Communications, Research and Development Cancer, MSD, keytruda, lung cancer, non-small cell lung cancer, pharma
MSD has revealed that its anti-PD-1 therapy Keytruda (pembrolizumab) has received expanded indication from the FDA to include the first-line …
Janssen’s Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis
April 12, 2019Medical Communications HIV, Janssen, Symtuza, pharma
Janssen has lifted the curtain on data from the first Phase 3 trial investigating the efficacy of Symtuza (darunavir 800mg, …
Top Ten most popular articles on Pharmafile.com this week!
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior
This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
Throat lozenges could be contributing to antimicrobial resistance
April 12, 2019Medical Communications AMR, Antibiotics, OTC, WHO, antimicrobial, health
Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year’s …
Opioid crisis cost US government nearly $38 billion in lost taxes
April 11, 2019Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue
The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …
Traffic pollution linked to four million childhood asthma cases each year
April 11, 2019Research and Development Air pollution, NO2, Traffic, asthma, emissions, pollution, public health
Air pollution is linked to four million cases of childhood asthma each year, according to research published in The Lancet …
Living with a rare chromosome disorder
April 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma
Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …
Reckitt Benckiser to unveil £105 R&D site in Hull by end of June
April 11, 2019Manufacturing and Production Hull, R&D, Reckitt Benckiser, UK, pharma
Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …
Researchers use CRISPR to reveal gene targets in 30 types of cancer
April 11, 2019Research and Development Cancer, crispr, drug development, genes, genetics, oncology
Researchers at the Wellcome Sanger Institute and Open Targets have been able to identify thousands of genes which play a …
Novartis’ Kisqali combo rejected by NICE for advanced breast cancer
April 11, 2019Sales and Marketing Kisqali, NHS, NICE, Novartis, pharma
Novartis’ Kisqali (ribociclib) has been rejected for use on the NHS by NICE for the treatment of advanced breast cancer, …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
